EP Patent

EP0197753A3 — Dihydrotestosterone heptanoate, its synthesis and methods of use thereof

Assigned to Baylor College of Medicine · Expires 1987-01-21 · 39y expired

What this patent protects

Disclosed is dihydrotestosterone heptanoate, its method of synthesis, and its method of use as an androgenic hormone of male gynecomastia, as a hormonal probe, as well as other applications.

USPTO Abstract

Disclosed is dihydrotestosterone heptanoate, its method of synthesis, and its method of use as an androgenic hormone of male gynecomastia, as a hormonal probe, as well as other applications.

Drugs covered by this patent

Patent Metadata

Patent number
EP0197753A3
Jurisdiction
EP
Classification
—
Expires
1987-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Baylor College of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.